Inhibikase Therapeutics (IKT) Gains (Losses) on Sale of Assets & Investments (2022 - 2026)
Inhibikase Therapeutics (IKT) recorded Non Operating Investment Income of -$46,461 in Q2 2026, compared with -$1,977 a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Gains (Losses) on Sale of Assets & Investments (2022 - 2026) Analysis & Trends
On a TTM basis, Inhibikase Therapeutics' Non Operating Investment Income came in at -$69,810 as of Jun 30, 2026; for FY2025, it came in at $59,050.
- Across earlier years, Non Operating Investment Income came in at -$38,125 in FY2024.
- Quarterly Non Operating Investment Income has ranged from -$167,536 in Q2 2023 to $36,281 in Q1 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$48,095 (Q1 2026), $25,991 (Q4 2025) and -$1,245 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -36,607.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -36,607.00 |
| Jun 30, 2026 | -46,461.00 |
| Mar 31, 2026 | -48,095.00 |
| Dec 31, 2025 | 25,991.00 |
| Sep 30, 2025 | -1,245.00 |
| Jun 30, 2025 | -1,977.00 |
| Mar 31, 2025 | 36,281.00 |
| Dec 31, 2024 | -39,002.00 |
| Sep 30, 2024 | 2,778.00 |
| Jun 30, 2024 | 776.00 |
| Mar 31, 2024 | -2,677.00 |
| Dec 31, 2023 | 1,020.00 |
| Sep 30, 2023 | 1,571.00 |
| Jun 30, 2023 | -167,536.00 |
| Mar 31, 2023 | 61,104.00 |
| Dec 31, 2022 | 77,890.00 |
| Sep 30, 2022 | 26,828.00 |
API Access
Inhibikase Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();